Upon declaration by the World Health Organisation (WHO) of the COVID-19 (Coronavirus) epidemic (now pandemic) in late January, Almac Pharma Services has been continually monitoring the situation relating to the global outbreak and its potential effect to our operations and employees, clients and ultimately patients.

We are committed to meeting client obligations, whilst continuing to ensure the utmost safety for our employees globally in doing so.

Almac Pharma Services’ situation overview:

Almac Pharma Management Team meets on a daily basis to review:

• The current status of outbreak.
• National and international updates including WHO situation reports, national government and health authority guidance.
• The status and wellbeing of our staff and business operational plans to ensure both staff safety and manage any impacts to our service delivery.

The wellbeing of our employees is Almac’s number one priority therefore during this time we appreciate your ongoing support and understanding as we work together to manage this challenging situation.

Our customer support teams will keep in regular contact with you as to the status of your projects, but should you have any additional concerns regarding your product or protocol, please do not hesitate to contact your client representative.

Click here to read Almac Group’s Response to the Coronavirus (COVID-19) Outbreak.